Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hulin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Progress in Medicinal Chemistry|January 1, 1994
New hypoglycaemic agentsB Hulin
Proceedings (Baylor University. Medical Center)|April 2, 2016
Use of ultrasound guidance to remove entrapped stimulating popliteal cathetersRussell K McAllister, James B Hulin, Don J Daniels
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1991
Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: metabolite identification by gas chromatography mass spectrometryH G Fouda, J Lukaszewicz, D A Clark, et al.
Journal of Medicinal Chemistry|September 27, 1996
Hypoglycemic activity of a series of alpha-alkylthio and alpha-alkoxy carboxylic acids related to ciglitazoneB Hulin, L S Newton, D M Lewis, et al.
Journal of Medicinal Chemistry|May 1, 1991
Benzyloxazolidine-2,4-diones as potent hypoglycemic agentsR L Dow, B M Bechle, T T Chou, et al.
Journal of Medicinal Chemistry|May 15, 1992
Novel thiazolidine-2,4-diones as potent euglycemic agentsB Hulin, D A Clark, S W Goldstein, et al.
Journal of Medicinal Chemistry|January 1, 1991
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agentsD A Clark, S W Goldstein, R A Volkmann, et al.
Diabetes|December 16, 2000
Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytesJ C Parker, R K McPherson, K M Andrews, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Progress in Medicinal Chemistry|January 1, 1994
New hypoglycaemic agentsB Hulin
Proceedings (Baylor University. Medical Center)|April 2, 2016
Use of ultrasound guidance to remove entrapped stimulating popliteal cathetersRussell K McAllister, James B Hulin, Don J Daniels
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1991
Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: metabolite identification by gas chromatography mass spectrometryH G Fouda, J Lukaszewicz, D A Clark, et al.
Journal of Medicinal Chemistry|September 27, 1996
Hypoglycemic activity of a series of alpha-alkylthio and alpha-alkoxy carboxylic acids related to ciglitazoneB Hulin, L S Newton, D M Lewis, et al.
Journal of Medicinal Chemistry|May 1, 1991
Benzyloxazolidine-2,4-diones as potent hypoglycemic agentsR L Dow, B M Bechle, T T Chou, et al.
Journal of Medicinal Chemistry|May 15, 1992
Novel thiazolidine-2,4-diones as potent euglycemic agentsB Hulin, D A Clark, S W Goldstein, et al.
Journal of Medicinal Chemistry|January 1, 1991
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agentsD A Clark, S W Goldstein, R A Volkmann, et al.
Diabetes|December 16, 2000
Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytesJ C Parker, R K McPherson, K M Andrews, et al.
Pageof 1